
|Articles|October 9, 2006
R.Ph.s can help reduce incidence of induced labor
Through-the-roof liability costs are convincing many hospitals to take measures to limit induced labor and the use of associated drugs, particularly the hormone oxytocin. "Inducing labor before 39 weeks places both mother and child at increased risk," said Kathy Connolly, assistant VP of risk management at Premier Inc., an alliance of 1,500 nonprofit hospitals.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
The Pharmacist’s Expertise in Managing Pneumococcal Diseases, Vaccines
2
What TrumpRx Means for Independent Pharmacies and Their Patients
3
Addressing Clinical Challenges and Expanding Pharmacy Roles | Recap ASHP Midyear 2025
4
Oral Semaglutide Show Promise as New Benchmark for Diabetes Care, Cardiovascular Protection
5






























































































































